Topic

stock plunge

A collection of 2 issues

Neumora Therapeutics Shares Plummet 80% After Drug Trial Failure

Neumora Therapeutics stock plummets 80% to $2.05 after pivotal Phase 3 trial of their depression drug fails, impacting investor confidence.

ADM Stock Plummets Amid Scandal and Canceled Earnings Call

ADM stock nosedives 24% due to a scandal, followed by another 12% drop after canceling its quarterly earnings call. Discover the impact on investors.